← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

EVP and General Counsel Karah Herdman Parschauer sold $441K of Ultragenyx Pharmaceutical Inc.

Sold$441,270
$45.00Price
9,806Shares
−14%Stake

What RARE did after the filing

Filed Jun 12Copier in Jun 13
The stock from Thu, Jun 13 open, $42.94
+5.4%
S&P 500, same days
+0.6%

Measured over 30 trading days, to the Jul 29 close.

Traded Wed, Jun 12. Filed Wed, Jun 12, 7:47 PM ET, after the close. Returns use the Jun 13 open and the Jul 29 close. Not investment advice.